Work

Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patients Ã¢ÂÂa phase 2 study

Year: 2021

Type: article

DOI: 10.35841/pulmonology-clinical.4.1.1-1

Author: Mark A. Socinski

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3154173462

FWCI:

Cites:

Cited by:

Related to: 10